Relapse of leukemia with loss of mismatched HLA resulting from uniparental disomy after haploidentical hematopoietic stem cell transplantation

Blood
Itzel Bustos VillalobosSeiji Kojima

Abstract

We investigated human leukocyte antigen (HLA) expression on leukemic cells derived from patients at diagnosis and relapse after hematopoietic stem cell transplantation (HSCT) using flow cytometry with locus-specific antibodies. Two of 3 patients who relapsed after HLA-haploidentical HSCT demonstrated loss of HLA alleles in leukemic cells at relapse; on the other hand, no loss of HLA alleles was seen in 6 patients who relapsed after HLA-identical HSCT. Single-nucleotide polymorphism array analyses of sorted leukemic cells further revealed the copy number-neutral loss of heterozygosity, namely, acquired uniparental disomy on the short arm of chromosome 6, resulting in the total loss of the mismatched HLA haplotype. These results suggest that the escape from immunosurveillance by the loss of mismatched HLA alleles may be a crucial mechanism of relapse after HLA-haploidentical HSCT. Accordingly, the status of mismatched HLA on relapsed leukemic cells should be checked before donor lymphocyte infusion.

References

Apr 17, 1990·Journal of Immunological Methods·S R Riddell, P D Greenberg
Apr 3, 2002·Seminars in Cancer Biology·Barbara SeligerSoldano Ferrone
Aug 8, 2002·The Journal of Immunology : Official Journal of the American Association of Immunologists·Eisei KondoYoshiki Akatsuka
Oct 31, 2002·Nature Immunology·Hung T Khong, Nicholas P Restifo
May 29, 2003·The Journal of Experimental Medicine·Yoshiki AkatsukaToshitada Takahashi
Nov 24, 2004·The Journal of Immunology : Official Journal of the American Association of Immunologists·Hiroki TorikaiToshitada Takahashi
Oct 24, 2007·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·Liang-Piu KohNelson J Chao
Nov 13, 2008·Seminars in Immunopathology·Andrea VelardiUNKNOWN Immunobiology Working Party of the European Group for Blood and Marrow Transplantation (EBMT)
Feb 28, 2009·Trends in Molecular Medicine·Musaffe TunaGordon B Mills
Jul 31, 2009·The New England Journal of Medicine·Luca VagoKatharina Fleischhauer

❮ Previous
Next ❯

Citations

Jan 27, 2012·Pediatric Research·Lena Oevermann, Rupert Handgretinger
Mar 30, 2012·Transplantation·Thomas R Spitzer
Aug 19, 2014·The Journal of Molecular Diagnostics : JMD·Marija DebeljakJames R Eshleman
Nov 19, 2010·Expert Review of Hematology·A John Barrett, Minoo Battiwalla
Oct 23, 2012·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·Chandra S BiswasOnder Alpdogan
Jul 26, 2011·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·Miguel WaterhouseJürgen Finke
May 29, 2012·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·Satoshi YoshiharaHiroyasu Ogawa
Mar 29, 2011·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·Yong-Xian HuHe Huang
Oct 4, 2011·Blood·Takamasa KatagiriUNKNOWN Japan Marrow Donor Program
Jun 15, 2016·HLA : Immune Response Genetics·D PlanellesJ L Vicario
Apr 29, 2016·Blood·Seishi Ogawa
Apr 20, 2018·Bone Marrow Transplantation·Mary HorowitzNicolaus Kröger
Jul 25, 2019·HLA : Immune Response Genetics·Antonio BalasJosé L Vicario
Dec 22, 2019·British Journal of Haematology·Sarah CharrotJude Fitzgibbon

❮ Previous
Next ❯

Related Concepts

Related Feeds

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.

Allogenic & Autologous Therapies

Allogenic therapies are generated in large batches from unrelated donor tissues such as bone marrow. In contrast, autologous therapies are manufactures as a single lot from the patient being treated. Here is the latest research on allogenic and autologous therapies.

Related Papers

The New England Journal of Medicine
Luca VagoKatharina Fleischhauer
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
L LuznikEphraim J Fuchs
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
Franco AversaMassimo F Martelli
Clinical Immunology : the Official Journal of the Clinical Immunology Society
Franco LocatelliLorenzo Moretta
© 2021 Meta ULC. All rights reserved